Evidence map›Paper›PMID 33240572›Full record

Trial reportTranslational vision science & technology2020

Evaluation of the IOP-Lowering Effect of a Multi-Pressure Dial at Different Negative Pressure Settings.

Russell J Swan, Tanner J Ferguson, Manjool Shah, Kelly W Muir, Thomas W Samuelson, Iqbal Ike K Ahmed, Richard L Lindstrom, Nathan M Radcliffe, John P Berdahl

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational vision science & technology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. New Devices in Glaucoma.Ophthalmology and therapy · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Russell J SwanVance Thompson Vision, Sioux Falls, South Dakota, USA.
Tanner J FergusonCole Eye Institute, Cleveland Clinic, Cleveland Ohio, USA.
Manjool ShahKellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
Kelly W MuirDuke Eye Center, Durham, North Carolina, USA.
Thomas W SamuelsonMinnesota Eye Consultants, Minneapolis, Minnesota, USA.
Iqbal Ike K AhmedPrism Eye Institute, Mississauga, Ontario, Canada.
Richard L LindstromMinnesota Eye Consultants, Minneapolis, Minnesota, USA.
Nathan M RadcliffeNew York Eye and Ear Infirmary of Mount Sinai, New York, New York.
John P BerdahlVance Thompson Vision, Sioux Falls, South Dakota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the intraocular pressure (IOP)-lowering effect of a multi-pressure dial (MPD) at targeted negative pressure settings. Methods: Prospective, intrasubject controlled study of 65 healthy subjects randomized to receive no negative pressure for 60 minutes or negative pressure application at designated levels of 25%, 50%, and 75% of baseline IOP for 20 minutes each. The main outcome measure was mean IOP with application of negative pressure. Results: In the study eye group, from a baseline IOP of 15.8 ± 3.6 mm Hg, the mean IOP was 13.5 ± 3.4, 11.5 ± 3.1, and 10.2 ± 2.7 mm Hg with negative pressure settings of 25%, 50% and 75%, respectively. In the control eye group, from a baseline IOP of 15.5 ± 3.0 mm Hg, the mean IOP values at the same time points, without negative pressure, were 15.6 ± 3.0, 15.5 ± 2.5 and 15.3 ± 2.4 mm Hg. The difference between the mean IOPs of the two groups was significantly different at all negative pressure settings ( Conclusions: Negative pressure application to the periocular space with a multi-pressure dial can produce titratable IOP reduction while the device is worn with active negative pressure. To our knowledge, this technology represents the first nonpharmacologic, nonlaser, nonsurgical method for IOP reduction. Translational Relevance: This represents the first study demonstrating the IOP-lowering ability of the multi-pressure dial, a device that uses a novel IOP-lowering strategy by delivering negative pressure to the periocular region.

Indexed as

Glaucoma, Open-AngleIntraocular PressureAntihypertensive AgentsHumansProspective StudiesTonometry, OcularAntihypertensive AgentsCSF pressureMPDmulti-pressure dialmulti-pressure glaucoma managementnormal tension glaucomaopen-angle glaucomasevere open-angle glaucoma

Identifiers

PMID33240572
PMCPMC7673999

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.